1. Tribute to Claudio Rapezzi
2. Giampaolo Merlini and the Pavia School
3. A brief history of amyloidosis
4. Pathophysiology, classification and epidemiology of amyloidosis
5. Amyloid light chain (AL) amyloidosis
6. Hereditary transthyretin amyloidosis
7. Wild-type ATTR amyloidosis
8. Electrocardiographic patterns
9. Echocardiography: a gatekeeper to diagnosis
10. Cardiovascular magnetic resonance: characterization of myocardial involvement
11. Biomarkers: monoclonal protein and indicators of cardiac damage
12. Plasma transthyretin and its ligands
13. Cardiac Scintigraphy with Bone-Avid Tracers - Old and New Applications
14. PET-CT: a tool for etiological diagnosis
15. The role of tissue biopsy: identification of the amyloid precursor and beyond
16. From red flags to diagnosis
17. Risk prediction and follow-up
18. Differential diagnoses in clinical mimics
19. Applications of Artificial Intelligence in Amyloidosis
20. Treatment of amyloid light-chain amyloidosis
21. Treatment of ATTR amyloidosis: from stabilizers to gene-editing
22. Treatment of cardiac complications
23. Monitoring disease progression and response to disease-modifying treatments
24. Cardiac amyloidosis: open issues and future perspectives.